“Beyond SIRS—Rethinking Sepsis Screening in the Hospital”
Event Navigation
Saxe Healthcare Communications & Philips Healthcare* present…“Beyond SIRS—Rethinking Sepsis Screening in the Hospital”
This webinar will provide an overview of the burden of sepsis in the hospital and review the current recommendations for sepsis management. Various published tools for sepsis screening, including SIRS and QSOFA, and comparing their accuracy to one another and general early warning scores, such as MEWS and NEWS will be discussed. Additionally, there will be a review of the limitations regarding the subjective assessment of sepsis, paying particular attention to whom is best situated to answer the question, “Do you suspect infection?” The presenter will share research using big data analytics to improve detection and decrease the burden of sepsis screening in the hospital and demonstrate how that can be integrated into the electronic medical record.
Learning Objectives | At the conclusion of this session, the learner should be able to:
- Describe the pros and cons of various sepsis screening approaches in the hospital
- Discuss how big data and real-time analytics are transforming the sepsis screening landscape
Speaker:
Dana Edelson, M.D., MS | Assistant Professor of Medicine | University of Chicago Medicine
Continuing Education for Nurses & Respiratory Therapists: This program has been approved for 1.0 contact hour of Continuing Education (CNE) credit by the California Board of Nursing, Provider #14477 and the Florida Board of Nursing, Provider #50-17032; and for 1.0 contact hour of Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care, 9425 N. MacArthur Blvd., Suite 100, Irving, TX 75063.
Educational support provided by Philips.
Questions should be directed to Emily Eberly at 513-579-0800; Producer@WebinarCreativeTechnology.com
* NOTE: This is a supplier and industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
